Here are four things to know:
1. With the exception of Germany, all countries in the seven major markets — the U.S., France, Germany, Italy, Spain, U.K. and Japan — will see an increase in diagnosed cases of Crohn’s disease.
2. The largest increases are expected in the U.S., France and Japan due to both increases in Crohn’s disease prevalence and population changes.
3. France is projected to have the highest annual growth rate of diagnosed Crohn’s disease at 4.04 percent, almost double the overall AGR of the seven major markets at 2.09 percent. Crohn’s disease is higher in women compared with men in France; risk factors for Crohn’s disease may vary by sex.
4. Changes in Crohn’s disease frequency disease have traditionally been thought of as a result of environmental factors, according to GlobalData healthcare analyst Nanthida Nanthavong.
More articles on gastroenterology:
The Gastroenterology Group offers patient access to clinical research — 5 insights
GI leader to know: Dr. Ammar Hemaidan of Advanced Medical Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.